Quest Diagnostics
DGX
$141.48
Share price
1.57%
Change (1 day)
3.38%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
EPS for Quest Diagnostics (DGX)
EPS in 2022 (TTM): $8.06
According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is $8.06. In 2021 the company made an earnings per share (EPS) of $15.87 an increase over its 2020 EPS that were of $10.60.
EPS history for Quest Diagnostics from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $8.06 | -49.21% |
| 2021 | $15.87 | 49.72% |
| 2020 | $10.60 | 66.67% |
| 2019 | $6.36 | 18% |
| 2018 | $5.39 | -4.26% |
| 2017 | $5.63 | 23.19% |
| 2016 | $4.57 | -7.11% |
| 2015 | $4.92 | 28.46% |
| 2014 | $3.83 | -31.61% |
| 2013 | $5.60 | 60.46% |
| 2012 | $3.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $13.93 | 72.83% | 🇺🇸 USA |
 Psychemedics PMD | -$0.36 | -104.47% | 🇺🇸 USA |
 NeoGenomics
NEO | -$1.16 | -114.39% | 🇺🇸 USA |
 Qiagen QGEN | $1.85 | -77.05% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | -$0.60 | -107.44% | 🇺🇸 USA |